Organon & Co | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Celltrion KRW 829.07B 829.07B 2025-03
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Divis Laboratories Ltd 4.15B 31.87B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Kangmei Pharma CNY 894.14M 120.63M 2025-03
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.62M 7.88M 2024-12
Merck USD 8.63B 4.61B 2025-03
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Novartis USD 11.46B 2.15B 2024-12
Organon & Co USD 547M 128M 2025-03
Pharma Mar EUR 60.29M 2.95M 2025-03
Qiagen NV USD 638.76M 24.8M 2025-03
Sartorius EUR 839.5M 26.1M 2025-03
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Tilray USD 189.7M 15.49M 2024-11



Organon & Co Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jun 2025.